Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Research into blue-ear pig disease
Cross-atlantic researchers study gene resistance

Collaborative research on blue-ear pig disease is set to begin at the Roslin Institute, Edinburgh University and Iowa State University.

The often fatal disease, otherwise known as porcine reproductive and respiratory syndrome (PRRS), is caused by a fast-mutating virus that affects pigs.

Iowa State University has received a $3 million (£2 million) grant by the US Department of Agriculture to research blue-ear, with the help of scientists from the Roslin Institute and Edinburgh University.

The research will look at whether some pigs have a genetic make-up that makes them less likely to succumb to infections, and whether breeding in any protective gene found will have a domino-effect on pigs' vulnerability to other diseases.


Blue-ear costs pork producers millions of pounds each year through reproductive failure and immune system defects in their livestock, as well as respiratory tract illness in young pigs.

Vaccine production is currently challenged because the virus evolves rapidly, causing continuous new strains.

Jack Dekkers, from Iowa State University, said: "This grant is going to help us continue our work towards finding a way for the pork industry to get a handle on a costly and difficult-to-control disease, and we're excited to move forward with our collaborations."

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'